148872-80-4 Usage
Uses
Used in Organic Synthesis:
2-(benzyloxy)-3-fluorophenol is used as a building block in organic synthesis for the creation of various biologically active compounds. Its unique structure allows for the development of new molecules with potential applications in different industries.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-(benzyloxy)-3-fluorophenol is used as a key intermediate in the synthesis of pharmaceuticals. Its presence in the molecular structure can influence the properties and effectiveness of the final drug product.
Used in Agrochemical Development:
2-(benzyloxy)-3-fluorophenol is utilized in the development of agrochemicals, where its chemical properties can contribute to the creation of new compounds with potential applications in agriculture, such as pesticides or herbicides.
Used in Materials Science:
In the field of materials science, 2-(benzyloxy)-3-fluorophenol is used as a component in the synthesis of new materials with unique properties. Its incorporation into materials can lead to advancements in areas such as polymers, coatings, or adhesives.
Used in Medicinal Chemistry and Drug Design:
2-(benzyloxy)-3-fluorophenol is employed in medicinal chemistry and drug design as a structural element that can be incorporated into new drug candidates. Its presence in a molecule can affect the drug's pharmacokinetics, pharmacodynamics, and overall therapeutic potential.
Check Digit Verification of cas no
The CAS Registry Mumber 148872-80-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,8,8,7 and 2 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 148872-80:
(8*1)+(7*4)+(6*8)+(5*8)+(4*7)+(3*2)+(2*8)+(1*0)=174
174 % 10 = 4
So 148872-80-4 is a valid CAS Registry Number.
148872-80-4Relevant academic research and scientific papers
MODULATORS OF DOPAMINE NEUROTRANSMISSION
-
, (2009/12/05)
The present invention relates to novel 1-(2,3-dihydro-1,4-benzodioxin-2-yl)- methanamine derivatives, useful as modulators of dopamine neurotransmission, and more specifically as dopaminergic stabilizers. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
